Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Integrated radiogenomics models predict response to neoadjuvant chemotherapy in high grade serous ovarian cancer.
Crispin-Ortuzar M, Woitek R, Reinius MAV, Moore E, Beer L, Bura V, Rundo L, McCague C, Ursprung S, Escudero Sanchez L, Martin-Gonzalez P, Mouliere F, Chandrananda D, Morris J, Goranova T, Piskorz AM, Singh N, Sahdev A, Pintican R, Zerunian M, Rosenfeld N, Addley H, Jimenez-Linan M, Markowetz F, Sala E, Brenton JD. Crispin-Ortuzar M, et al. Among authors: zerunian m. Nat Commun. 2023 Oct 24;14(1):6756. doi: 10.1038/s41467-023-41820-7. Nat Commun. 2023. PMID: 37875466 Free PMC article.
MRI of the endometrium - from normal appearances to rare pathology.
Pintican R, Bura V, Zerunian M, Smith J, Addley H, Freeman S, Caruso D, Laghi A, Sala E, Jimenez-Linan M. Pintican R, et al. Among authors: zerunian m. Br J Radiol. 2021 Sep 1;94(1125):20201347. doi: 10.1259/bjr.20201347. Epub 2021 Jul 8. Br J Radiol. 2021. PMID: 34233457 Free PMC article. Review.
Clinically Interpretable Radiomics-Based Prediction of Histopathologic Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma.
Rundo L, Beer L, Escudero Sanchez L, Crispin-Ortuzar M, Reinius M, McCague C, Sahin H, Bura V, Pintican R, Zerunian M, Ursprung S, Allajbeu I, Addley H, Martin-Gonzalez P, Buddenkotte T, Singh N, Sahdev A, Funingana IG, Jimenez-Linan M, Markowetz F, Brenton JD, Sala E, Woitek R. Rundo L, et al. Among authors: zerunian m. Front Oncol. 2022 Jun 16;12:868265. doi: 10.3389/fonc.2022.868265. eCollection 2022. Front Oncol. 2022. PMID: 35785153 Free PMC article.
Deep learning-based segmentation of multisite disease in ovarian cancer.
Buddenkotte T, Rundo L, Woitek R, Escudero Sanchez L, Beer L, Crispin-Ortuzar M, Etmann C, Mukherjee S, Bura V, McCague C, Sahin H, Pintican R, Zerunian M, Allajbeu I, Singh N, Sahdev A, Havrilesky L, Cohn DE, Bateman NW, Conrads TP, Darcy KM, Maxwell GL, Freymann JB, Öktem O, Brenton JD, Sala E, Schönlieb CB. Buddenkotte T, et al. Among authors: zerunian m. Eur Radiol Exp. 2023 Dec 7;7(1):77. doi: 10.1186/s41747-023-00388-z. Eur Radiol Exp. 2023. PMID: 38057616 Free PMC article.
Radiomic Cancer Hallmarks to Identify High-Risk Patients in Non-Metastatic Colon Cancer.
Caruso D, Polici M, Zerunian M, Del Gaudio A, Parri E, Giallorenzi MA, De Santis D, Tarantino G, Tarallo M, Dentice di Accadia FM, Iannicelli E, Garbarino GM, Canali G, Mercantini P, Fiori E, Laghi A. Caruso D, et al. Among authors: zerunian m. Cancers (Basel). 2022 Jul 15;14(14):3438. doi: 10.3390/cancers14143438. Cancers (Basel). 2022. PMID: 35884499 Free PMC article.
Radiomics in Oncology III.
Zerunian M, Laghi A, Caruso D. Zerunian M, et al. Diagnostics (Basel). 2023 Jan 1;13(1):149. doi: 10.3390/diagnostics13010149. Diagnostics (Basel). 2023. PMID: 36611441 Free PMC article.
48 results